Complications of Unsafe and Self-Managed Abortion

N Engl J Med. 2020 Mar 12;382(11):1029-1040. doi: 10.1056/NEJMra1908412.

Authors

Lisa H Harris¹, Daniel Grossman¹

Affiliation

¹ From the Department of Obstetrics and Gynecology and the Department of Women's Studies, University of Michigan, Ann Arbor (L.H.H.); and the Department of Obstetrics, Gynecology, and Reproductive Sciences, Advancing New Standards in Reproductive Health (ANSIRH), and the Bixby Center for Global Reproductive Health, University of California, San Francisco, San Francisco (D.G.).

PMID: 32160664
DOI: 10.1056/NEJMra1908412

No abstract available

Publication types

Review

MeSH terms

Abortifacient Agents, Nonsteroidal / administration & dosage
Abortion, Induced / adverse effects*
Abortion, Induced / legislation & jurisprudence
Abortion, Spontaneous* / diagnosis
Abortion, Spontaneous* / therapy
Adult
Diagnosis, Differential
Female
Health Policy
Humans
Mifepristone / administration & dosage
Misoprostol / administration & dosage
Pregnancy
Self-Management*
United States

Substances

Abortifacient Agents, Nonsteroidal
Misoprostol
Mifepristone